Aitia

Aitia

Biotechnology, 233 Vaughan St, Somerville, Massachusetts, 03801, United States, 51-200 Employees

aitiabio.com

  • LinkedIn

phone no Phone Number: +12*********

Who is AITIA

Aitia is the leader in the development and application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs in neurodegenerative disorders, oncology, and i...

Read More

map
  • 233 Vaughan St, Somerville, Massachusetts, 03801, United States Headquarters: 233 Vaughan St, Somerville, Massachusetts, 03801, United States
  • 2000 Date Founded: 2000
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $50 Million to $100 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 7361 | NAICS Code: 561311 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from AITIA

Aitia Org Chart and Mapping

Employees

Igor Nemer

Senior Data Operations Engineer

Pahriya Ashrap

Senior Research Scientist

Andre Lucas

Health Safety Environment

Laurel Mayhew

Senior Director of Early Development

Scott McKay

Chief Technology Officer

Dan Kamalic

Senior Manager, Devops, Hpc/Cloud Architect

Emily Nicol

Human Resources Specialist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Aitia

Answer: Aitia's headquarters are located at 233 Vaughan St, Somerville, Massachusetts, 03801, United States

Answer: Aitia's phone number is +12*********

Answer: Aitia's official website is https://aitiabio.com

Answer: Aitia's revenue is $50 Million to $100 Million

Answer: Aitia's SIC: 7361

Answer: Aitia's NAICS: 561311

Answer: Aitia has 51-200 employees

Answer: Aitia is in Biotechnology

Answer: Aitia contact info: Phone number: +12********* Website: https://aitiabio.com

Answer: Aitia is the leader in the development and application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs in neurodegenerative disorders, oncology, and immunology. By leveraging the convergence of multi-omic patient data, high-performance computing, and causal learning and AI, Aitia is revealing the hidden biological mechanisms of disease to create Digital Twins. Gemini Digital Twins are being used today to discover novel therapies and accelerate R&D in Alzheimers Disease, Parkinsons Disease, Huntingtons Disease, multiple myeloma, prostate cancer, and pancreatic cancer, with several more in development. Aitias partners include six of the top ten pharmaceutical companies, leading academic research and medical centers, medical societies, leading multi-omic data companies, and patient advocacy groups globally.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access